{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:50:56Z","timestamp":1791939056987,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T00:00:00Z","timestamp":1710374400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Institute of Aging","award":["P30-AG024832"],"award-info":[{"award-number":["P30-AG024832"]}]},{"name":"Exeter-UBCO Sports Health Science Fund Project Grant"},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2019-05204"],"award-info":[{"award-number":["RGPIN-2019-05204"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["PJT-169116"],"award-info":[{"award-number":["PJT-169116"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Aims\/hypothesis<\/jats:title>\n                <jats:p>The aim of the present study was to conduct a randomised, placebo-controlled, double-blind, crossover trial to determine whether pre-meal ketone monoester ingestion reduces postprandial glucose concentrations in individuals with type 2 diabetes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this double-blind, placebo-controlled, crossover design study, ten participants with type 2 diabetes (age 59\u00b11.7 years, 50% female, BMI 32\u00b11 kg\/m<jats:sup>2<\/jats:sup>, HbA<jats:sub>1c<\/jats:sub> 54\u00b12 mmol\/mol [7.1\u00b10.2%]) were randomised using computer-generated random numbers. The study took place at the Nutritional Physiology Research Unit, University of Exeter, Exeter, UK. Using a dual-glucose tracer approach, we assessed glucose kinetics after the ingestion of a 0.5 g\/kg body mass ketone monoester (KME) or a taste-matched non-caloric placebo before a mixed-meal tolerance test. The primary outcome measure was endogenous glucose production. Secondary outcome measures were total glucose appearance rate and exogenous glucose appearance rate, glucose disappearance rate, blood glucose, serum insulin, \u03b2-OHB and NEFA levels, and energy expenditure.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Data for all ten participants were analysed. KME ingestion increased mean \u00b1 SEM plasma beta-hydroxybutyrate from 0.3\u00b10.03 mmol\/l to a peak of 4.3\u00b11.2 mmol\/l while reducing 2 h postprandial glucose concentrations by ~18% and 4 h postprandial glucose concentrations by ~12%, predominately as a result of a 28% decrease in the 2 h rate of glucose appearance following meal ingestion (all <jats:italic>p<\/jats:italic>&lt;0.05). The reduction in blood glucose concentrations was associated with suppressed plasma NEFA concentrations after KME ingestion, with no difference in plasma insulin concentrations between the control and KME conditions. Postprandial endogenous glucose production was unaffected by KME ingestion (mean \u00b1 SEM 0.76\u00b10.15 and 0.88\u00b10.10 mg kg<jats:sup>\u20131<\/jats:sup> min<jats:sup>\u20131<\/jats:sup> for the control and KME, respectively). No adverse effects of KME ingestion were observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions\/interpretation<\/jats:title>\n                <jats:p>KME ingestion appears to delay glucose absorption in adults with type 2 diabetes, thereby reducing postprandial glucose concentrations. Future work to explore the therapeutic potential of KME supplementation in type 2 diabetes is warranted.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT05518448.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Funding<\/jats:title>\n                <jats:p>This project was supported by a Canadian Institutes of Health Research (CIHR) Project Grant (PJT-169116) and a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant (RGPIN-2019-05204) awarded to JPL and an Exeter\u2013UBCO Sports Health Science Fund Project Grant awarded to FBS and JPL.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00125-024-06122-7","type":"journal-article","created":{"date-parts":[[2024,3,14]],"date-time":"2024-03-14T08:45:39Z","timestamp":1710405939000},"page":"1107-1113","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["A ketone monoester drink reduces postprandial blood glucose concentrations in adults with type 2 diabetes: a randomised controlled trial"],"prefix":"10.1007","volume":"67","author":[{"given":"Alistair J.","family":"Monteyne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaja","family":"Falkenhain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gr\u00e1inne","family":"Whelehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Neudorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doaa R.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Murton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Wall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis B.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,14]]},"reference":[{"key":"6122_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.yrtph.2012.04.008","volume":"63","author":"K Clarke","year":"2012","unstructured":"Clarke K, Tchabanenko K, Pawlosky R et al (2012) Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. Regul Toxicol Pharmacol 63:401\u2013408. https:\/\/doi.org\/10.1016\/j.yrtph.2012.04.008","journal-title":"Regul Toxicol Pharmacol"},{"key":"6122_CR2","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.1093\/advances\/nmac036","volume":"13","author":"K Falkenhain","year":"2022","unstructured":"Falkenhain K, Daraei A, Forbes SC, Little JP (2022) Effects of exogenous ketone supplementation on blood glucose: a systematic review and meta-analysis. Adv Nutr 13:1697\u20131714. https:\/\/doi.org\/10.1093\/advances\/nmac036","journal-title":"Adv Nutr"},{"key":"6122_CR3","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1093\/ajcn\/nqz232","volume":"110","author":"\u00c9 Myette-C\u00f4t\u00e9","year":"2019","unstructured":"Myette-C\u00f4t\u00e9 \u00c9, Caldwell HG, Ainslie PN, Clarke K, Little JP (2019) A ketone monoester drink reduces the glycemic response to an oral glucose challenge in individuals with obesity: a randomized trial. Am J Clin Nutr 110:1491\u20131501. https:\/\/doi.org\/10.1093\/ajcn\/nqz232","journal-title":"Am J Clin Nutr"},{"key":"6122_CR4","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1113\/JP275709","volume":"596","author":"\u00c9 Myette-C\u00f4t\u00e9","year":"2018","unstructured":"Myette-C\u00f4t\u00e9 \u00c9, Neudorf H, Rafiei H, Clarke K, Little JP (2018) Prior ingestion of exogenous ketone monoester attenuates the glycaemic response to an oral glucose tolerance test in healthy young individuals. J Physiol 596:1385\u20131395. https:\/\/doi.org\/10.1113\/JP275709","journal-title":"J Physiol"},{"key":"6122_CR5","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1111\/jdi.13423","volume":"12","author":"T Nakagata","year":"2021","unstructured":"Nakagata T, Tamura Y, Kaga H et al (2021) Ingestion of an exogenous ketone monoester improves the glycemic response during oral glucose tolerance test in individuals with impaired glucose tolerance: a cross-over randomized trial. J Diabetes Investig 12:756\u2013762. https:\/\/doi.org\/10.1111\/jdi.13423","journal-title":"J Diabetes Investig"},{"key":"6122_CR6","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.2337\/dc09-0723","volume":"32","author":"J Ma","year":"2009","unstructured":"Ma J, Stevens JE, Cukier K et al (2009) Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes. Diabetes Care 32:1600\u20131602. https:\/\/doi.org\/10.2337\/dc09-0723","journal-title":"Diabetes Care"},{"key":"6122_CR7","doi-asserted-by":"publisher","first-page":"2062","DOI":"10.1210\/jc.2005-2644","volume":"91","author":"D Gentilcore","year":"2006","unstructured":"Gentilcore D, Chaikomin R, Jones KL et al (2006) Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes. J Clin Endocrinol Metabol 91:2062\u20132067. https:\/\/doi.org\/10.1210\/jc.2005-2644","journal-title":"J Clin Endocrinol Metabol"},{"key":"6122_CR8","doi-asserted-by":"publisher","first-page":"e3974","DOI":"10.1371\/journal.pone.0003974","volume":"3","author":"CD Dotson","year":"2008","unstructured":"Dotson CD, Zhang L, Xu H et al (2008) Bitter taste receptors influence glucose homeostasis. PLOS ONE 3:e3974. https:\/\/doi.org\/10.1371\/journal.pone.0003974","journal-title":"PLOS ONE"},{"key":"6122_CR9","doi-asserted-by":"publisher","first-page":"26649","DOI":"10.1074\/jbc.C500213200","volume":"280","author":"AKP Taggart","year":"2005","unstructured":"Taggart AKP, Kero J, Gan X et al (2005) (d)-\u03b2-Hydroxybutyrate inhibits adipocyte lipolysis via the nicotinic acid receptor PUMA-G. J Biol Chem 280:26649\u201326652. https:\/\/doi.org\/10.1074\/jbc.C500213200","journal-title":"J Biol Chem"},{"key":"6122_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0140-6736(63)91500-9","volume":"281","author":"PJ Randle","year":"1963","unstructured":"Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 281:785\u2013789. https:\/\/doi.org\/10.1016\/S0140-6736(63)91500-9","journal-title":"Lancet"},{"key":"6122_CR11","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1073\/pnas.56.1.247","volume":"56","author":"JR Williamson","year":"1966","unstructured":"Williamson JR, Kreisberg RA, Felts PW (1966) Mechanism for the stimulation of gluconeogenesis by fatty acids in perfused rat liver. Proc Natl Acad Sci 56:247\u2013254. https:\/\/doi.org\/10.1073\/pnas.56.1.247","journal-title":"Proc Natl Acad Sci"},{"key":"6122_CR12","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1210\/jcem-52-1-34","volume":"52","author":"JM Miles","year":"1981","unstructured":"Miles JM, Haymond MW, Gerich JE (1981) Suppression of glucose production and stimulation of insulin secretion by physiological concentrations of ketone bodies in man. J Clin Endocrinol Metab 52:34\u201337. https:\/\/doi.org\/10.1210\/jcem-52-1-34","journal-title":"J Clin Endocrinol Metab"},{"key":"6122_CR13","doi-asserted-by":"publisher","first-page":"e14385","DOI":"10.1111\/dme.14385","volume":"38","author":"M Svart","year":"2021","unstructured":"Svart M, Rittig N, Pedersen SB, Jessen N, M\u00f8ller N (2021) Oral 3-hydroxybutyrate ingestion decreases endogenous glucose production, lipolysis, and hormone-sensitive lipase phosphorylation in adipose tissue in men: a human randomized, controlled, crossover trial. Diabetic Med 38:e14385. https:\/\/doi.org\/10.1111\/dme.14385","journal-title":"Diabetic Med"},{"key":"6122_CR14","doi-asserted-by":"publisher","first-page":"E717","DOI":"10.1152\/ajpendo.1998.275.4.E717","volume":"275","author":"G Livesey","year":"1998","unstructured":"Livesey G, Wilson PDG, Dainty JR et al (1998) Simultaneous time-varying systemic appearance of oral and hepatic glucose in adults monitored with stable isotopes. Am J Physiol Endocrinol Metab 275:E717\u2013E728. https:\/\/doi.org\/10.1152\/ajpendo.1998.275.4.E717","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"6122_CR15","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1172\/JCI72227","volume":"124","author":"E Ferrannini","year":"2014","unstructured":"Ferrannini E, Muscelli E, Frascerra S et al (2014) Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Investig 124:499\u2013508. https:\/\/doi.org\/10.1172\/JCI72227","journal-title":"J Clin Investig"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-024-06122-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-024-06122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T11:03:35Z","timestamp":1714388615000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-024-06122-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,14]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["6122"],"URL":"https:\/\/doi.org\/10.1007\/s00125-024-06122-7","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,14]]},"assertion":[{"value":"28 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Data that support the findings of this study are available from the corresponding author on reasonable request.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}},{"value":"This project was supported by a Canadian Institutes of Health Research (CIHR) Project Grant (PJT-169116) and a Natural Sciences and Engineering Research Council (NSERC) Discovery Grant (RGPIN-2019-05204) awarded to JPL and an Exeter\u2013UBCO Sports Health Science Fund Project Grant awarded to FBS and JPL. AnJM and DRA are supported in part by a National Institute of Aging grant (P30-AG024832).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"JPL is Chief Scientific Officer for the Institute for Personalized Therapeutic Nutrition, a registered charity in Canada. JPL holds founders shares in Metabolic Insights, a company that develops non-invasive metabolic monitoring devices. All other authors declare that there are no relationships or activities that might bias, or be perceived to bias, their work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 relationships and activities"}},{"value":"AlJM, KF, HN, BTW, FBS and JPL were involved in the conception and design of the study. AlJM, KF, HN, GW, BTW and FBS were involved in the conduct of the study. AlJM, KF, DRA, AnJM, FBS and JPL were involved in the analysis and interpretation of the results. AlJM, KF, FBS and JPL wrote the first draft of the manuscript and all authors edited, reviewed and approved the final version for publication. JPL is the guarantor of this work and, as such, had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contribution statement"}}]}}